By the close of the 1942 season, Ted Williams became a fighter pilot and flight instructor in the U.S. Marine Corps, all through World War II. He served through 1945 and
making his return to the Red Sox in the Spring of 1946, Pushing the team to win the American League pennant and taking home the MVP award. Despite the fact the Red Sox lost
the World Series (the only one Williams played in) to the St. Louis Cardinals that year, Williams'spreeminenceas an outstanding hitter grewby leaps and bounds. He became known
as the Splendid Splinter and the Thumper, for his 6'3" rail-thin frame and his power behind the bat was also ca;lled the kid.
In 1947, Williams won his second Triple Crown but lost the MVP title to DiMaggio by only one vote, a slight by the sportswriters that Williams in no way forgot.
In 1949, he was voted American League MVP for the second time. In 1950, while having a momentous season, Williams fractured his elbow during the All-Star Game at
Comiskey Park in Chicago; he smashed into the wall while catching a fly ball. He finished that game, but the damage cost him more than sixty games, despite the fact
he played well during the games he did play. He hit .318 in 1951 but then went back into the military service in 1952 and 1953, for the duration of the Korean War.
After a crash landing of his fighter plane and a bout with pneumonia, he was sent back to the states. He announced his retirement from baseball in 1954 but then changed
his mind and stayed on with the Red Sox, because he would have been ineligible for Hall of Fame election on the first ballot if he quit too soon. He suffered a series of
injuries in the mid-1950s, but in 1957, at almost forty years old, he hit .388 and became the oldest player to ever win a batting championship. He hit .453 during the second
half of the season. Williams was more popular than ever before and finished second only to Mickey Mantle in MVP balloting. The following year, Williams batted .328,
still high enough to lead the league in batting. During this part of his career he won the nickname Teddy Ballgame, although his favorite nickname for himself
was always "The Kid."
http://www.baberuthautographedbaseball.org/mickey-mantle-autographed-baseball/
Amongst sports activities memorabilia Mickey Mantle baseball cards are probably the most treasured objects. It
http://www.baberuthautographedbaseball.org/mickey-mantle-baseball-card/
Baseball cards might be one your best investments in present day economy. When you think of baseball cards, you might consider kids operating around trading cards back and forth - reading the stats around the again with the card and collecting their favorite players. However baseball cards and taken on the whole new which means with today
This season, more than ever before, Major League Baseball® is experiencing an explosion of young talent, a changing of the guard; as rookies and young stars are making a bigger impact on the league than ever before.
The Topps Company celebrates this passing of the torch with the release of 2014 Topps Baseball Series 1, which features these exciting new stars while also looking back at the greatest players of today and yesterday. Additionally, Topps is giving fans who purchase 2014 Topps Baseball Series 1 the chance to win highly-coveted Topps’ Top 50 Rookie Cards from years past, including Mickey Mantle, Hank Aaron, Johnny Bench, Derek Jeter, Miguel Cabrera and more.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7101153-topps-company-baseball-series-1-power-players
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor. This new approach to treating blood cancers works by blocking BTK, a protein that helps certain cancer cells live and grow.1 IMBRUVICA is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL), or adult patients with chronic lymphocytic leukaemia (CLL) who have received at least one prior therapy, or in first line in the presence of 17p deletion or TP53 mutation in patients unsuitable for chemo-immunotherapy.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762540-janssen-ec-approval-imbruvica-mcl-cll/
Hallmark Signature Collection holiday cards are truly unique, just like a signature. The exquisite textures, premium quality paper, fun embellishments, and relevant messages are sure to help Hallmark Signature Collection cards become holiday favorites to place on the mantle and be appreciated for several seasons.
“These cards are perfect for shoppers who like sophisticated, dimensional designs,” said Dan Foster, Hallmark Vice President of Creative Commercialization Greetings. “Consumers told us they wanted cards that were meaningful and authentic, as well as surprising, unexpected, and appropriate for a keepsake.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/59627-hallmark-signature-collection-holiday-cards-a-distinctive-experience
The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running.
The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?
The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia).
To view the multimedia release go to:
http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/